SEC Form D · filed June 1, 2017
Arbor Biotechnologies, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
David R. Walt · Waltham, MADirectorWinston X. Yan · CAMBRIDGE, MAExecDavid A. Scott · CAMBRIDGE, MAExecAnnie X. Hazlehurst · CAMBRIDGE, MADirectorFeng R. Zhang · CAMBRIDGE, MADirectorKeith X. Crandell · CAMBRIDGE, MADirectorP. R. Morrow, Ii · Dallas, TXDirectorMichael E. Olshan · Dallas, TXExecCampbell C. Lewis · Dallas, TXExecShane Albers · Scottsdale, AZDirectorWilliam Abraham · New Brighton, MNDirectorCraig Brazeau · Plainfield, ILDirectorMichael Demane · New Brighton, MNDirectorTony Borowicz · New Brighton, MNExecAmy Boyle · New York, NYExecThomas Feldstein · New York, NYDirectorThomas Shapiro · New York, NYDirectorRobert Vahradian · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗